CA3066742A1 - Compositions and methods for enhancing hyperthermia therapy - Google Patents

Compositions and methods for enhancing hyperthermia therapy

Info

Publication number
CA3066742A1
CA3066742A1 CA3066742A CA3066742A CA3066742A1 CA 3066742 A1 CA3066742 A1 CA 3066742A1 CA 3066742 A CA3066742 A CA 3066742A CA 3066742 A CA3066742 A CA 3066742A CA 3066742 A1 CA3066742 A1 CA 3066742A1
Authority
CA
Canada
Prior art keywords
selenium
fish oil
cancer cell
yeast
sensitizer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3066742A
Other languages
English (en)
French (fr)
Inventor
Houn Simon Hsia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA3066742A1 publication Critical patent/CA3066742A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Indole Compounds (AREA)
CA3066742A 2017-06-13 2018-06-13 Compositions and methods for enhancing hyperthermia therapy Pending CA3066742A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762519090P 2017-06-13 2017-06-13
US62/519,090 2017-06-13
PCT/US2018/037268 WO2018231938A1 (en) 2017-06-13 2018-06-13 Compositions and methods for enhancing hyperthermia therapy

Publications (1)

Publication Number Publication Date
CA3066742A1 true CA3066742A1 (en) 2018-12-20

Family

ID=64562472

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3066742A Pending CA3066742A1 (en) 2017-06-13 2018-06-13 Compositions and methods for enhancing hyperthermia therapy

Country Status (9)

Country Link
US (3) US10905724B2 (https=)
EP (1) EP3638270B1 (https=)
JP (2) JP7336994B2 (https=)
KR (1) KR102773006B1 (https=)
CN (2) CN120695037A (https=)
CA (1) CA3066742A1 (https=)
IL (1) IL271327B2 (https=)
TW (1) TWI823853B (https=)
WO (1) WO2018231938A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL265786B (en) * 2016-10-03 2022-09-01 Houn Simon Hsia Materials and methods for increasing radiotherapy against cancer
IL271327B2 (en) * 2017-06-13 2024-11-01 Simon Hsia Houn Compositions for increasing tumor sensitivity to hyperthermia therapy
US20220175850A1 (en) * 2019-04-01 2022-06-09 Houn Simon Hsia Compositions and methods for cancer therapy
US20210393579A1 (en) * 2020-06-23 2021-12-23 Zestt Wellness Limited Anthocyanin and Quercetin Based Formulations for Improved Respiratory Health
CN115462488B (zh) * 2022-10-08 2024-01-16 河南师范大学 鞣花酸作为饲料添加剂的应用，功能性饲料及制备方法

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US988092A (en) * 1909-11-22 1911-03-28 Celfor Tool Company Drill.
US4348483A (en) 1981-01-23 1982-09-07 Universal Foods Corporation Method for the production of chromium yeast
US4569836A (en) 1981-08-27 1986-02-11 Gordon Robert T Cancer treatment by intracellular hyperthermia
CA2010511A1 (en) * 1989-03-01 1990-09-01 Roberto L. Ceriani Method of enhancing cancer therapy by administration of unsaturated fatty acids
NZ248605A (en) 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
US20020010144A1 (en) 1994-04-29 2002-01-24 Robert Sobol Enhancing the sensitivity of tumor cells to therapies
US5976548A (en) 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US6440464B1 (en) 1996-06-10 2002-08-27 Viva Life Science Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates
US6197295B1 (en) 1996-09-25 2001-03-06 Viva America Marketing Corporation Dietary supplementation with, and methods for administration of yeast-derived selenium product
US5810888A (en) 1997-06-26 1998-09-22 Massachusetts Institute Of Technology Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery
CA2339473A1 (en) 1998-08-04 2000-02-17 John V. Kosbab Nutrient and therapeutic compositions for the treatment of cancer
AU5319499A (en) * 1999-07-22 2001-02-13 Ivan L. Cameron Fatty acids to minimize cancer therapy side effects
US7569551B2 (en) 2000-02-25 2009-08-04 The University Of British Columbia Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
US20050080468A1 (en) * 2001-03-26 2005-04-14 Lawrence C. Christman Methods and apparatus for treating diseased tissue
US7731648B2 (en) 2001-07-25 2010-06-08 Aduro Biotech Magnetic nanoscale particle compositions, and therapeutic methods related thereto
EP1438971A4 (en) * 2001-10-25 2005-01-12 Ttc Co Ltd IMMUNE AMPLIFIERS IN THERAPEUTIC THERAPY IN CANCER
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
US7744930B2 (en) 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US8663679B2 (en) 2004-04-29 2014-03-04 Abbott Laboratories Compositions for improving breast health in women
US9107864B2 (en) * 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US20060088574A1 (en) 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
US20070116802A1 (en) 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
US8017147B2 (en) 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
US20090110674A1 (en) 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
WO2009091597A2 (en) 2008-01-16 2009-07-23 Nanospectra Biosciences, Inc. Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
AU2008361497B2 (en) 2008-09-04 2014-07-17 Takeshi Kobayashi Methods and kits for hyperthermia and CTLA4 inhibitory therapy
EP3011843A1 (en) 2008-09-19 2016-04-27 Nestec S.A. Nutritional support of the immune system during anti-cancer treatment
US8257694B2 (en) 2009-05-14 2012-09-04 Product Partners, Llc Nutritional compositions for reducing oxidative damage
KR20120065276A (ko) * 2009-05-29 2012-06-20 뉴 챕터, 인코포레이티드. 지질 조성을 조정하기 위한 조성물 및 방법
KR101275724B1 (ko) 2009-12-09 2013-06-17 한국전자통신연구원 단일 기판 집적 회로 장치 및 그 제조 방법
WO2011094579A2 (en) 2010-01-29 2011-08-04 New Chapter Inc. Mushroom compositions and methods for making and using
JP5882889B2 (ja) 2010-03-15 2016-03-09 国立大学法人 岡山大学 抗腫瘍剤
US20120010688A1 (en) 2010-07-09 2012-01-12 Lamb Karl J Implantable conductive element and method of use inhyperthermic treatment
CN103026807B (zh) 2010-07-26 2016-01-20 莱尔德技术股份有限公司 适用于emi屏蔽应用的具有可控压缩形变的高导电聚合物泡沫的制造处理
US9669053B2 (en) * 2010-07-26 2017-06-06 Chemotherapeutics, Llc Compositions and methods for enhancing the effectiveness of systemic, HIPEC, IP, and related cancer treatments
US9642925B2 (en) 2010-12-07 2017-05-09 Sanford Research/USD Magnetic nanoparticle formulations, methods for making such formulations, and methods for their use
WO2012122295A2 (en) 2011-03-07 2012-09-13 Ned Biosystems, Inc. Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin
CN102349699B (zh) 2011-07-04 2013-07-03 郑俊祥 一种电子烟液的制备方法
US9609457B2 (en) 2012-07-27 2017-03-28 Crexendo, Inc. Mobile application procurement and configuration options for VOIP service
WO2014054884A1 (ko) 2012-10-05 2014-04-10 연세대학교 산학협력단 민감화 물질을 포함하는 온열 치료용 조성물
US9072768B2 (en) 2013-01-22 2015-07-07 Kibow Biotech, Inc. Composition and method for increasing effectiveness of radiation or chemotherapy
US9107947B2 (en) 2013-01-31 2015-08-18 The Penn State Research Foundation Anti-cancer compositions and methods
WO2014159851A2 (en) * 2013-03-13 2014-10-02 The Board Of Regents Of The University Of Texas System Novel low density lipoprotein nanocarriers for targeted delevery of omega-3 polyunsaturated fatty acids to cancer
DE202013002760U1 (de) 2013-03-21 2014-06-23 Cc Pharma Gmbh Nahrungsergänzungsmittel zur medikationsorientierten Supplementierung
US20140294795A1 (en) * 2013-03-28 2014-10-02 Houn Simon Hsia Nutritional Composition
MX370055B (es) * 2013-04-22 2019-11-29 Smartfish As Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer.
SG11201600657RA (en) 2013-07-31 2016-02-26 Meiji Co Ltd Nutritional composition for inhibiting growth of tumor
EP3033091B1 (en) 2013-08-16 2022-09-07 Versitech Limited Probiotic composition and use thereof in the prevention and treatment of hepatocellular carcinoma
CN104082736A (zh) * 2014-06-13 2014-10-08 胡安然 一种调理乳腺癌的方便食品
US20170246136A1 (en) * 2014-09-24 2017-08-31 OliVentures, Inc. Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases
CN105641000A (zh) * 2015-06-01 2016-06-08 深圳市康道生物有限公司 一种含灰树花提取物的抗肿瘤组合物及其制备方法
JP7411327B2 (ja) 2015-11-18 2024-01-11 サイバーグ・コンサルティング・リミテッド・ライアビリティ・カンパニー 天然抽出物を含有する組成物、ならびに皮膚および毛髪に対するその使用
CN105617358A (zh) 2015-12-29 2016-06-01 广州市戴菊科技发展有限公司 一种具有抗肿瘤功能的医用食品及其制备方法
CN105768108A (zh) 2016-03-10 2016-07-20 福格森（武汉）生物科技股份有限公司 一种适用于肿瘤患者服用的特膳食品
JP6376186B2 (ja) 2016-08-04 2018-08-22 トヨタ自動車株式会社 サスペンションメンバ
IL265786B (en) 2016-10-03 2022-09-01 Houn Simon Hsia Materials and methods for increasing radiotherapy against cancer
CN106822560A (zh) 2017-04-07 2017-06-13 湖北工程学院 药物组合物及其制备方法
EP3638269B1 (en) 2017-06-13 2025-12-17 Houn Simon Hsia Nutritional supplement for enhancing cancer radiotherapy
US10905725B2 (en) 2017-06-13 2021-02-02 Houn Simon Hsia Compositions and methods for enhancing cancer chemotherapy
IL271327B2 (en) 2017-06-13 2024-11-01 Simon Hsia Houn Compositions for increasing tumor sensitivity to hyperthermia therapy
JP2020121479A (ja) 2019-01-30 2020-08-13 オリンパス株式会社 射出成形金型

Also Published As

Publication number Publication date
WO2018231938A1 (en) 2018-12-20
US11896624B2 (en) 2024-02-13
US11433105B2 (en) 2022-09-06
KR102773006B1 (ko) 2025-02-24
US20180353550A1 (en) 2018-12-13
EP3638270B1 (en) 2023-10-25
IL271327B2 (en) 2024-11-01
CN120695037A (zh) 2025-09-26
KR20200078468A (ko) 2020-07-01
TW201902492A (zh) 2019-01-16
US10905724B2 (en) 2021-02-02
JP2023105154A (ja) 2023-07-28
JP7336994B2 (ja) 2023-09-01
JP2020523375A (ja) 2020-08-06
US20210154241A1 (en) 2021-05-27
EP3638270A4 (en) 2021-06-30
TWI823853B (zh) 2023-12-01
IL271327B1 (en) 2024-07-01
EP3638270A1 (en) 2020-04-22
US20220354903A1 (en) 2022-11-10
CN111479578A (zh) 2020-07-31
IL271327A (en) 2020-01-30

Similar Documents

Publication Publication Date Title
US11896624B2 (en) Compositions for enhancing hyperthermia therapy
JP7465313B2 (ja) がん放射線療法を増強するための組成物および方法
ES3013603T3 (en) A composition for weight loss or weight management comprising beta-hydroxybutyrate and cannabidiol
Prasad Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity
US11541079B2 (en) Compositions and methods for enhancing cancer immunotherapy
AU2020200726B2 (en) Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues
CA3066713A1 (en) Compositions and methods for enhancing cancer chemotherapy
Prasad Antioxidants in cancer care: when and how to use them as an adjunct to standard and experimental therapies
US20240350558A1 (en) Compositions and Methods for Treating Inflammation
CN109954052A (zh) 一种具有抗氧化活性的组合物
HK40031147A (en) Compositions and methods for enhancing hyperthermia therapy
Demers A Holistic Approach for the Treatment of Cancer
SALE L-Glutamine with Theracurmin–306 grams
HK40011860A (en) Compositions and methods for enhancing cancer radiotherapy

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20230515

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20240925

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250115

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250517

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250517

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - SMALL

Year of fee payment: 7

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250528

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250528